Thalidomide in refractory and relapsing multiple myeloma

被引:28
作者
Bladé, J [1 ]
Esteve, J [1 ]
Rosiñol, L [1 ]
Perales, M [1 ]
Montoto, S [1 ]
Tuset, M [1 ]
Montserrat, E [1 ]
机构
[1] Univ Barcelona, Hosp Clin,IDIBAPS, Hematol Dept,Pharm Serv,Inst Invest Biomed August, Inst Hematol & Oncol,Postgrad Sch Hematol Farrera, Barcelona 08036, Spain
关键词
D O I
10.1043/sonc.2001.28610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:588 / 592
页数:5
相关论文
共 18 条
[1]   A RANDOMIZED TRIAL OF MAINTENANCE VERSUS NO MAINTENANCE MELPHALAN AND PREDNISONE IN RESPONDING MULTIPLE-MYELOMA PATIENTS [J].
BELCH, A ;
SHELLEY, W ;
BERGSAGEL, D ;
WILSON, K ;
KLIMO, P ;
WHITE, D ;
WILLAN, A .
BRITISH JOURNAL OF CANCER, 1988, 57 (01) :94-99
[2]  
BERGSAGEL DE, 1998, MYELOMA BIOL MANAGEM, P270
[3]  
Bladé J, 2000, ACTA ONCOL, V39, P843
[4]   Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas [J].
Bladé, J ;
Perales, M ;
Rosiñol, L ;
Tuset, M ;
Montoto, S ;
Esteve, O ;
Cobo, F ;
Villela, L ;
Rafel, M ;
Nomdedeu, B ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :422-424
[5]  
Blade J, 2001, Hematol J, V2, P272, DOI 10.1038/sj.thj.6200115
[6]  
BLADE J, 2002, BRIT J HAEMATOL, V102, P1115
[7]  
BRANDES LJ, 1987, EUR J HAEMATOL, V39, P362
[8]   Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy [J].
Hideshima, T ;
Chauhan, D ;
Shima, Y ;
Raje, N ;
Davies, FE ;
Tai, YT ;
Treon, SP ;
Lin, B ;
Schlossman, RL ;
Richardson, P ;
Muller, G ;
Stirling, DI ;
Anderson, KC .
BLOOD, 2000, 96 (09) :2943-2950
[9]   Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma [J].
Juliusson, G ;
Celsing, F ;
Turesson, I ;
Lenhoff, S ;
Adriansson, M ;
Malm, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) :89-96
[10]  
Kneller A, 2000, BRIT J HAEMATOL, V108, P391